Industry insights from our own scientists, publicists, developers, designers, strategists and more.

Our experts have spent their careers learning their craft, honing their skills and implementing the most effective marketing, engagement and public relations strategies to help healthcare and science brands transform the world. Let's dive in, shall we?

Our latest posts

AI’s Omnipresence and the Necessity of the Human Touch

Generative artificial intelligence (AI) has recently grabbed the public’s imagination.


Chicago, Chicago, That Biotech Town

Last month, a Chicago-based biotech company called CellTrans was on the receiving end of a remarkable regulatory milestone: The company received FDA approval for the first cellular therapy for Type-1 diabetes.


HDMZ Named Top 10 Employer in Fortune’s Best Workplaces in Chicago 2023: Recognition Shows Our Plan to Serve Clients Even Better is Working

At HDMZ, we have a big, hairy, audacious goal: We aim to be the most admired marketing communications agency in the world for life sciences and biotech.


5 Developments in Cancer Research that HDMZ is Watching

Molecular biomarkers, precision medicine and artificial intelligence (AI) are all contributing to rapid developments in oncology.


Lifestyle and Diet Changes at the Heart Of Rise in Cancer in Younger People

A recent study published in Nature revealed that since the ‘90s, cancer has been on the rise in people under the age of 50.

Life Sciences

Site Performance Analysis: Avoid Bias with a Data-Driven Approach

3 data-driven approaches to help avoid bias and optimize user experience when building a website.

Big Data

HDMZ Adds Denis Moore to Leadership Team

As HDMZ’s new senior vice president of finance, Denis will oversee the agency’s financial operations to help achieve its business growth objectives and vision

Press Releases

Technology and communication channels may change, but great stories remain timeless

At HDMZ, we focus on telling great stories to help brands making a difference in the world get the attention they deserve. It’s reflective of our agency’s culture, and is woven into the fabric of our DNA.


With Major Government Support, Biotech and Life Sciences Likely Heading Into Innovation Renaissance

Read this week’s blog post to see how Biden’s new executive order may spark biotech, healthcare and life sciences innovations and startups.


Regulatory Review: Unsung FDA approvals for rare disease in the 3rd quarter

In Q3 2022, several rare disease therapies became the first approved for their indications. Read more about under-the-radar FDA approvals for rare disease.